OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Completed

Conditions studied: Cancer

In brief

RATIONALE: Studying protein expression in sentinel lymph node tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This laboratory study is evaluating OX-40 protein expression in the sentinel lymph nodes of patients with cancer.

Key facts

Study ID

NCT00900302

Run by

OHSU Knight Cancer Institute

People needed

98

Starts

2005-04-01

Expected to finish

2011-03-01

Last updated by the study team

2016-02-10

Who can join

Age: any, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• OHSU Knight Cancer Institute — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.